Abstract
HBx and MHBst products from hepatitis B virus-DNA (HBV-DNA), which become transcriptional transactivators of cellular and viral genes, are known to play causative roles in the development of hepatocellular carcinoma (HCC). However, the biomolecular mechanism(s) for their roles in hepatocarcinogenesis in vivo remain poorly understood. To identify authentic cellular genes involved in HBx and MHBst-transactivated carcinogenesis, we used mRNA differential display polymerase chain reaction (DD-PCR). We examined HBx and MHBs-positive or -negative HCC, which had chromosomally integrated HBV DNA, vs nontumor tissues, respectively, and differentially expressed genes in either type of HCC were identified and compared with each other. Using 240 different combinations of three one-base anchored oligo-dT primers and 80 arbitrary 13mers, 16 genes were differentially expressed in the HBx and MHBs-positive HCC including Ro RNA hY1, glutamine synthetase, factor H homologue 3′ end, voltage-dependent anion channel 3 (VDAC3), three ribosomal proteins, four mitochondrial genes, and four novel genes. Unexpectedly, upregulated genes in association with functional HBV proteins were different from those reportedly transactivated by HBV viral proteins in vitro. Ten genes were downregulated, including three novel genes. In contrast, 15 genes in HCC tissue negative for HBx and MHBs-expression were preferentially expressed including pancreatic secretory trypsin inhibitor (PSTI), H19, guanidine nucleotide-binding protein α-1 subunit (GNAZ), carbamyl phosphate synthetase I (CPS I), insulin-like growth factor (IGF)-II, and 10 ribosomal proteins genes. Eighteen genes were downregulated including acute phase genes, a novel gene, and particularly the retinoblastoma susceptibility gene. Only two genes (ribosomal protein P0 and L37a) were commonly upregulated in both types of HCC tissues. These results suggest that cellular genes involved in the viral protein—transactivation may generally differ from those not associated with transactivation in established HCC, and that the specific oncogenic coordination through the transactivation by viral proteins which works in experiments in vitro, may play only a potential role in hepatocarcinogenesis in vivo. In addition, the functional analyses of the eight novel genes identified in this study might be valuable to further understand the mechanism(s) of hepatocarcinogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Koshy, R., Maupas, P., Müller, R., and Hofschneider, P. H. (1981) Detection of hepatitis B virus-specific DNA in the genome of human hepatocellular carcinoma and liver cirrhosis tissues. J. Gen. Virol. 57, 95–102.
Buendia, M. A. (1992) Mammalian hepatitis B virus and primary liver cancer. Semin. Cancer Biol. 3, 309–320.
Chen, P.-J., Chen, D.-S., Lai, M.-Y., et al. (1989) Clonal origin of recurrent hepatocellular carcinoma. Gastroenterology 96, 527–529.
Lugassy, C., Bernuau, J., Thiers, V., et al. (1987) Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. J. Infect. Dis. 155, 64–71.
Twu, J. S. and Schoemer, R. H. (1987) Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61, 3448–3453.
Spandau, D. F. and Lee, C. H. (1988) Trans-activation of viral enhancers by the hepatitis B virus X protein. J. Virol. 62, 427–434.
Caselmann, W. H., Meyer, M., Kekule, A. S., and Lauer, U. (1990) A trans-activator function is generated by integrated of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc. Natl. Acad. Sci. USA 87, 2970–2974.
Kekule, A. S., Lauer, U., Caselmann, W. H., Hofschneider, P. H., and Koshy, R. (1990) The preS/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343, 457–461.
Benn, J., Su, F., Doria, M., and Schneider, R. J. (1996) Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinase. J. Virol. 70, 4978–4985.
Seto, E., Mitchell, T. J., and Yen, T. S. (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcriptional factors. Nature 344, 72–74.
Maguire, H. F., Hoffler, J. P., and Siddiqui, A. (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interaction. Science 252, 842–844.
Mahe, Y., Mukasida, N., Kuno, K., et al. (1991) Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements. J. Biol. Chem. 266, 13,759–13,763.
Siddiqui, A., Gynor, R., Srinivasan, A., Mapoles, J., and Wesley-Farr, R. (1989) Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the B virus X protein. Virology 169, 479–484.
Chirillo, P., Falco, M., Puri, P. L., et al. (1999) Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J. Virol. 70, 641–646.
Aufiero, B., and Schneider, R. J. (1990) The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 9, 497–504.
Lara-Pezzi, E., Majano, P. L., Gomez-Gonzalo, M., et al. (1998) The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes. Hepatology 28, 1013–1021.
Amaro, M. J., Bartolome, J., and Carreno, V. (1999) Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter. Hepatology 29, 915–923.
Lauer, U., Weiss, L., Lipp, M., Hofschneider, P. H., and Kekulé, A. S. (1992) The hepatitis B virus transactivator is generated by 3′ truncation within a defined region of the S gene. J. Virol. 66, 5284–5289.
Lauer, U., Weiss, L., Hofschneider, P. H., and Kekulé, A. S. (1994) The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19, 23–31.
Meyer, M., Caselmann, W. H., Schluter, V., Schreck, R., Hofschneider, P. H., and Baeuerle, P. A. (1992) Hepatitis B virus transactivator MHBst: activation of NF-κB, selective inhibition by antioxidant and integral membrane localization. EMBO J. 11, 2991–3001.
Schluter, V., Meyer, M., Hofschneider, P. H., Koshy, R., Caselmann, and W. H. (1994) Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatoma encode functionally active transactivators. Oncogene 9, 3335–3344.
Scheuer, P. J. (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatology 13, 372–374.
Kim, D.-G., Lee, D.-Y., Cho, B.-H., You, K.-R., Kim, M.-Y., and Ahn, D.-S. (1999) Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid. Hepatology 29, 1091–1098.
Liang, P. and Pardee, A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.
Liang, P., Zhu, W., Zhang, X., et al. (1994) Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res. 22, 5763–5764.
Kim, M. Y., Park, E., Park, J. H., et al. (2001) Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas. Oncogene 20, 4568–575.
Kim, D. G., You, K. R., Liu, M. J., Choi, Y. K., Won, Y. S. (2002) GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells. J. Biol. Chem. 277, 38,930–38,938.
Kim, J. H., You, K. R., Kim, I. H. Cho, B. H., Kim, C. Y. and Kim, D. K. (2004) Over-expression of the ribosomal protein L36a (RPL36A) gene is associated with tumor cell proliferation in hepatocellular carcinoma. Hepatology 39, 129–138.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Kim, DG. (2006). Differentially Expressed Genes Associated With Hepatitis B Virus HBx and MHBs Protein Function in Hepatocellular Carcinoma. In: Liang, P., Meade, J.D., Pardee, A.B. (eds) Differential Display Methods and Protocols. Methods in Molecular Biology, vol 317. Humana Press. https://doi.org/10.1385/1-59259-968-0:141
Download citation
DOI: https://doi.org/10.1385/1-59259-968-0:141
Publisher Name: Humana Press
Print ISBN: 978-1-58829-338-1
Online ISBN: 978-1-59259-968-4
eBook Packages: Springer Protocols